Matches in Nanopublications for { ?s ?p "[CXCL1-inhibting agents such as endostatin may constitute a useful approach to treat the malignant or intermediate vascular lesions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- assertion description "[CXCL1-inhibting agents such as endostatin may constitute a useful approach to treat the malignant or intermediate vascular lesions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[CXCL1-inhibting agents such as endostatin may constitute a useful approach to treat the malignant or intermediate vascular lesions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1215612.RArDhNUkJoRzKrUI3F_lBvjh_iv4vqKQm68zfGn63eV8s130_assertion description "[CXCL1-inhibting agents such as endostatin may constitute a useful approach to treat the malignant or intermediate vascular lesions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1215612.RArDhNUkJoRzKrUI3F_lBvjh_iv4vqKQm68zfGn63eV8s130_provenance.
- NP1215618.RAGVNRA_pRUQ8AyeER2zwT4hUuugagETg4pKjZw0zzTEE130_assertion description "[CXCL1-inhibting agents such as endostatin may constitute a useful approach to treat the malignant or intermediate vascular lesions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1215618.RAGVNRA_pRUQ8AyeER2zwT4hUuugagETg4pKjZw0zzTEE130_provenance.